Clover Health Investments Corp reports results for the quarter ended March 31 - Earnings Summary
Clover Health Investments CorpQ) reported breakeven earnings per share for the quarter ended March 31, surpassing last year's EPS of -4 cents and beating analyst expectations of a loss of 6 cents. Revenue increased by 33.3% to $462.33 million, though it fell short of the $499.56 million forecast. The company reported a quarterly loss of $1.27 million. Analyst ratings remain mixed, with an average recommendation of "hold" and a median 12-month price target of $4.50.
Clover Health Investments Corp (CLOV.OQ) reported quarterly breakeven results per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -4 cents. The mean expectation of four analysts for the quarter was for a loss of 6 cents per share. Wall Street expected results to range from -7 cents to -6 cents per share.
Revenue rose 33.3% to $462.33 million from a year ago; analysts expected $499.56 million.
Clover Health Investments Corp’s reported EPS for the quarter was breakeven results.
The company reported a quarterly loss of $1.27 million.
Clover Health Investments Corp shares had fallen by 6.7% this quarter and gained 6.3% so far this year. FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 44.4% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS
The current average analyst rating on the shares is “hold” and the breakdown of recommendations is 2 “strong buy” or “buy,” 3 “hold” and no “sell” or “strong sell.” The average consensus recommendation for the managed healthcare peer group is also “hold”
Wall Street’s median 12-month price target for Clover Health Investments Corp is $4.50 This summary was machine generated from LSEG data May 6 at 10:12 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2025 -0.06 0.00 Beat
Dec. 31 2024 -0.06 -0.04 Beat
Sep. 30 2024 -0.04 -0.02 Beat
Jun. 30 2024 -0.05 0.01 Beat
